Stocktoria

INNOSPEC INC. IOSP

Nasdaq · stock · Chemicals & Allied Products · website · IPO 1998-05-13 · LEI

INNOSPEC INC. financials (annual)

Revenue
$883.4M $1.31B $1.48B $1.51B $1.19B $1.48B $1.96B $1.95B $1.85B $1.78B 2016201720182019202020212022202320242025
Net income
2016201720182019202020212022202320242025
Free cash flow
2016201720182019202020212022202320242025

Bars are annual figures from 2016 to 2025; red bars are negative (a loss or cash outflow).

MetricFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue$1.8B$1.8B$1.9B$2.0B$1.5B$1.2B$1.5B$1.5B$1.3B$883.4M
Gross profit$492.4M$542.9M$591.1M$586.7M$434.9M$342.7M$466.2M$435.0M$403.3M$332.3M
R&D expense$51.0M$56.5M$49.0M$38.7M$37.4M$30.9M$35.4M$33.4M$31.4M$25.4M
SG&A expense$285.1M$305.3M$380.5M$360.7M$267.2M$237.0M$280.9M$261.0M$244.2M$216.7M
Operating income$129.5M$177.9M$161.6M$187.3M$132.1M$33.7M$149.9M$133.5M$125.0M$98.2M
Income tax$21.5M$5.6M$35.3M$51.6M$41.3M$11.0M$38.2M$46.6M$66.3M$21.8M
Operating cash flow$138.3M$184.5M$207.3M$81.7M$93.2M$145.9M$161.6M$104.9M$82.7M$105.5M
Cash & equivalents$292.5M$289.2M$203.7M$147.1M$141.8M$105.3M$75.7M$123.1M$90.2M$101.9M
Inventory$329.3M$301.0M$300.1M$373.1M$277.6M$220.0M$244.6M$248.0M$209.8M$173.8M
Total assets$1.8B$1.7B$1.7B$1.6B$1.6B$1.4B$1.5B$1.5B$1.4B$1.2B
Total liabilities$499.5M$518.6M$557.8M$563.3M$537.9M$647.9M$615.9M$527.6M
Shareholders' equity$1.3B$1.2B$1.1B$1.0B$1.0B$944.9M$918.9M$825.5M$794.3M$653.8M
EPS (diluted)$4.67$1.42$5.56$5.32$3.75$1.16$4.54$3.45$2.52$3.33

Growth · year-over-year · Revenue CAGR 8.1%

MetricFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue growth-3.7%-5.3%-0.8%+32.4%+24.3%-21.2%+2.5%+13.0%+47.9%-12.7%
EPS growth+228.9%-74.5%+4.5%+41.9%+223.3%-74.4%+31.6%+36.9%-24.3%-31.5%

Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.

Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.